Civic Intelligence

Cns Gene Therapy Consortium

EIN 23-3032900 • 501(c)3 • Philadelphia, PA

Profile

To promote gene therapy research relevant to neurologic disorders, including but not limited to parkinson's disease.

1500 Jfk Blvd Suite 1450Philadelphia, PA 19102

n/A

Siviq Scores

Precomputed percentiles relative to similar nonprofits. These scores are descriptive rather than judgmental.

Liabilities / Assets

99th percentile

24.48x

Higher debt load relative to assets than 99% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2017

Liabilities / Revenue

100th percentile

163.55x

Higher debt load relative to revenue than 100% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2017

Net Margin

97th percentile

89%

Higher net margin than 97% of similar nonprofits.

501(c)3 • <$500k nonprofits • Source year 2017

Top Officer Pay

81st percentile

$0

Higher top officer pay than 81% of similar nonprofits.

Top officer pay equals 0.0% of source-year revenue.

501(c)3 • <$500k nonprofits • Source year 2017

Asset Growth

73rd percentile

15%

Faster asset growth than 73% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Revenue Growth

10th percentile

-77%

Faster revenue growth than 10% of similar nonprofits.

501(c)3 • <$500k nonprofits • Annualized from 2016 to 2017

Balance Sheet
Liabilities / Assets99th percentile

Assets

Up

$922

Up $123 (+15%) from 2016

Liabilities

Flat

$22,570

Flat from 2016

Net Assets

Up

-$21,648

Up $123 (+0.6%) from 2016

Operations
Liabilities / Revenue100th percentileNet Margin97th percentile

Revenue

Down

$138

Down $462 (-77%) from 2016

Expenses

Down

$15

Down $1,300 (-99%) from 2016

Net Income

Up

$123

Up $838 (+117%) from 2016

Trend Graphs

Balance Sheet Trend

Asset Growth73rd percentile

Grouped bars show assets, liabilities, and net assets across loaded filings.

$40K$20K$0-$20K-$40KAssets 2010: $3,350Liabilities 2010: $22,570Net Assets 2010: -$19,2202010Assets 2011: $2,555Liabilities 2011: $22,570Net Assets 2011: -$20,0152011Assets 2012: $2,009Liabilities 2012: $22,570Net Assets 2012: -$20,5612012Assets 2013: $1,416Liabilities 2013: $22,570Net Assets 2013: -$21,1542013Assets 2014: $0Liabilities 2014: $22,908Net Assets 2014: -$22,9082014Assets 2015: $1,514Liabilities 2015: $22,570Net Assets 2015: -$21,0562015Assets 2016: $799Liabilities 2016: $22,570Net Assets 2016: -$21,7712016Assets 2017: $922Liabilities 2017: $22,570Net Assets 2017: -$21,6482017

Highlighted filing

2017

Assets$922
Liabilities$22,570
Net Assets-$21,648
Open 2017 Filing

Operations Trend

Revenue Growth10th percentile

Revenue, expenses, and net income by year, with the latest filing highlighted.

$80K$60K$40K$20K$0-$20KExpenses 2010: $44,7582010Expenses 2011: $60,7942011Expenses 2012: $19,0112012Revenue 2013: $16,226Expenses 2013: $16,819Net Income 2013: -$5932013Revenue 2014: $12,195Expenses 2014: $13,949Net Income 2014: -$1,7542014Revenue 2015: $16,363Expenses 2015: $14,511Net Income 2015: $1,8522015Revenue 2016: $600Expenses 2016: $1,315Net Income 2016: -$7152016Revenue 2017: $138Expenses 2017: $15Net Income 2017: $1232017

Highlighted filing

2017

Revenue$138
Expenses$15
Net Income$123
Open 2017 Filing

Filings

Most recent year

2017 • Form 990XML pending. An XML filing is linked for this year, but detailed extraction is still pending.

Open filing
Assets
$922
Liabilities
$22,570
Net assets
-$21,648
Revenue
$138
Expenses
$15
Net income
$123
Balance SheetOperations
YearAssetsLiabilitiesNet AssetsRevenueExpensesNet Income
2017XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.92$22.6$21.6$0.14$0.02$0.12
2016XML pending. An XML filing is linked for this year, but detailed extraction is still pending.$0.80$22.6$21.8$0.60$1.32$0.72
2015Detailed filing. Detailed filing data is available for this year.$1.51$22.6$21.1$16.4$14.5$1.85
2014Detailed filing. Detailed filing data is available for this year.$0.00$22.9$22.9$12.2$13.9$1.75
2013Detailed filing. Detailed filing data is available for this year.$1.42$22.6$21.2$16.2$16.8$0.59
2012Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.01$22.6$20.6$19.0
2011Facts available. Structured filing facts are available, but richer extracted sections are limited.$2.56$22.6$20.0$60.8
2010Facts available. Structured filing facts are available, but richer extracted sections are limited.$3.35$22.6$19.2$44.8
Latest Detailed Filing

The latest 2017 filing currently has linked XML that has not been fully parsed yet. Showing the latest detailed filing from 2015 below.

Jump To
Filing Snapshot
Filing Period
Jan 1, 2015 to Dec 31, 2015
Signed
May 12, 2016
Return Version
2015v2.1
Gross Receipts
$16,363
Mission and Program Overview

Mission

To promote gene therapy research relevant to neurologic disorders, including but not limited to parkinson's disease.

Balance Sheet Detail
LineBeginningEndChange
Assets
Loans From Officers Directors$22,908$22,570▼ $338
Cash and Non-Interest-Bearing Accounts-$1,514-
Rtn Earn Endowment Incm Other Fnds$-22,908$-21,056▲ $1,852
Total Assets$0$1,514▲ $1,514
Liabilities
Total Liabilities$22,908$22,570▼ $338
Net Assets / Fund Balance
Total Net Assets Fund Balance$-22,908$-21,056▲ $1,852
Total Liabilities and Net Assets / Fund Balance$0$1,514▲ $1,514

Asset Categories

AssetBook ValueDepreciationBasis
Other Land Buildings-$10,638$10,638
Compensation and Service Providers
Top Officer Pay81st percentile

Board Members and Trustees

NameTitle
Andrew Freese Md PhdPresident
Revenue and Support

Revenue Composition

Contributions and Grants
$16,363
Program Service Revenue
$0
Investment Income
$0
Other Revenue
$0
All Other Contributions
$16,363
Change in Net Assets
$1,852
Expenses and Functional Allocation

Major Expense Lines

Line ItemAmount
Other Expenses$14,511
Grants and Similar Amounts Paid$0
Professional Fundraising Fees$0
Salaries, Compensation, and Employee Benefits$0
Total Fundraising Expense$0

Functional Expense Allocation

Line ItemProgramManagementFundraisingTotal
Occupancy-$11,500-$11,500
Fees for Services Accounting-$2,600-$2,600
Office Expenses-$411-$411
Total Functional Expenses$0$14,511$0$14,511
Fundraising, Events, and Gaming
Fundraising activities
No
Gaming activities
No
Professional fundraiser used
No

Fundraising and Gaming Totals

Line ItemAmount
Professional Fundraising Fees$0
Political and Lobbying Activity
Political campaign activity
No
Lobbying activity
No
Subject to proxy tax
No
Insider Transactions and Loans

Loans and Receivables

Line ItemBeginningEndChange
Loans from Officers, Directors, Trustees, and Key Employees$22,908$22,570▼ $338
Governance and Compliance

Governance Checklist

Compiled or reviewed by an accountant
Yes
Backup withholding compliance
No
Business relationship with family members
No
Business relationship with organization members
No
Material changes to governing documents
No
Compensation from other sources disclosed
No
CEO compensation reviewed
No
Other officer compensation reviewed
No
Conflict-of-interest policy
No
Audited financial statements prepared
No
Key decisions subject to board approval
No
Management duties delegated
No

Governance Explanations

Form 990, Page 6, Part VI, Line 11B

“No review was or will be conducted.”

Form 990, Page 6, Part VI, Line 19

“Records and financials are kept on site and made available upon request.”

Filing and Contact Details

Filer

Filer Name
Cns Gene Therapy Consortium
EIN
23-3032900
Phone
2675148950
Address
1500 JFK BLVD SUITE 1450, PHILADELPHIA, PA 19102

Signing Officer

Name
Andrew Freese Md Phd
Title
President
Phone
2675148950
Signed
2016-05-12
Discuss with paid preparer
Yes

Organization Details

Principal Officer
Andrew Freese Md Phd
Formed
2000
Legal Domicile
Pa
Voting Board Members
1
Independent Board Members
0
Employees
0

Preparer

Firm
Jw Kelly Associates LLC
Address
1 BELMONT AVE STE 412, BALA CYNWYD, PA 19004-1607
Preparer
Regina W Kelly CPA
Phone
6106647000
Supplemental Narrative

Additional Explanations

Form 990, Page 2, Part III, Line 4D

“To support research for parkinson's disease gene therapy, anticipate publication of proceedings in "experimental neurology- and disseminate information on novel gene therapy approaches.”

Form 990, Part XI, Line 9

“ROUNDING 0”

Raw XML Appendix259 raw XML fields

This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.

Path#Value
IRS990/AccountantCompileOrReviewInd0true
IRS990/AcctCompileOrReviewBasisGrp/SeparateBasisFinclStmtInd0X
IRS990/ActivitiesConductedPrtshpInd0false
IRS990/ActivityOrMissionDesc0TO PROMOTE GENE THERAPY RESEARCH RELEVANT TO NEUROLOGIC DISORDERS, INCLUDING BUT NOT LIMITED TO PARKINSON'S DISEASE.
IRS990/AllOtherContributionsAmt016363
IRS990/BackupWthldComplianceInd0false
IRS990/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt0ANDREW FREESE MD PHD
IRS990/BooksInCareOfDetail/PhoneNum02675148950
IRS990/BooksInCareOfDetail/USAddress/AddressLine1Txt01803 PINE STREET STE 1
IRS990/BooksInCareOfDetail/USAddress/CityNm0PHILADELPHIA
IRS990/BooksInCareOfDetail/USAddress/StateAbbreviationCd0PA
IRS990/BooksInCareOfDetail/USAddress/ZIPCd019103
IRS990/BusinessRlnWithFamMemInd0false
IRS990/BusinessRlnWithOfficerEntInd0false
IRS990/BusinessRlnWithOrgMemInd0false
IRS990/CashNonInterestBearingGrp/EOYAmt01514
IRS990/ChangeToOrgDocumentsInd0false
IRS990/CollectionsOfArtInd0false
IRS990/CompensationFromOtherSrcsInd0false
IRS990/CompensationProcessCEOInd0false
IRS990/CompensationProcessOtherInd0false
IRS990/ConflictOfInterestPolicyInd0false
IRS990/ConservationEasementsInd0false
IRS990/ConsolidatedAuditFinclStmtInd0false
IRS990/CreditCounselingInd0false
IRS990/CYBenefitsPaidToMembersAmt00
IRS990/CYContributionsGrantsAmt016363
IRS990/CYGrantsAndSimilarPaidAmt00
IRS990/CYInvestmentIncomeAmt00
IRS990/CYOtherExpensesAmt014511
IRS990/CYOtherRevenueAmt00
IRS990/CYProgramServiceRevenueAmt00
IRS990/CYRevenuesLessExpensesAmt01852
IRS990/CYSalariesCompEmpBnftPaidAmt00
IRS990/CYTotalExpensesAmt014511
IRS990/CYTotalFundraisingExpenseAmt00
IRS990/CYTotalProfFndrsngExpnsAmt00
IRS990/CYTotalRevenueAmt016363
IRS990/DecisionsSubjectToApprovaInd0false
IRS990/DeductibleArtContributionInd0false
IRS990/DeductibleNonCashContriInd0false
IRS990/DelegationOfMgmtDutiesInd0false
IRS990/Desc0TO SUPPORT RESEARCH FOR PARKINSON'S DISEASE GENE THERAPY, ANTICIPATE PUBLICATION OF PROCEEDINGS IN "EXPERIMENTAL NEUROLOGY- AND DISSEMINATE INFORMATION ON NOVEL GENE THERAPY APPROACHES.
IRS990/DescribedInSection501c3Ind0true
IRS990/DisregardedEntityInd0false
IRS990/DocumentRetentionPolicyInd0false
IRS990/DonorAdvisedFundInd0false
IRS990/ElectionOfBoardMembersInd0false
IRS990/EmployeeCnt00
IRS990/EngagedInExcessBenefitTransInd0false
IRS990/FamilyOrBusinessRlnInd0false
IRS990/FeesForServicesAccountingGrp/ManagementAndGeneralAmt02600
IRS990/FeesForServicesAccountingGrp/TotalAmt02600
IRS990/ForeignActivitiesInd0false
IRS990/ForeignFinancialAccountInd0false
IRS990/ForeignOfficeInd0false
IRS990/Form990PartVIISectionAGrp/OfficerInd0X
IRS990/Form990PartVIISectionAGrp/OtherCompensationAmt00
IRS990/Form990PartVIISectionAGrp/PersonNm0ANDREW FREESE MD PHD
IRS990/Form990PartVIISectionAGrp/ReportableCompFromOrgAmt00
IRS990/Form990PartVIISectionAGrp/ReportableCompFromRltdOrgAmt00
IRS990/Form990PartVIISectionAGrp/TitleTxt0PRESIDENT
IRS990/Form990ProvidedToGvrnBodyInd0true
IRS990/FormationYr02000
IRS990/FormerOfcrEmployeesListedInd0false
IRS990/FSAuditedInd0false
IRS990/FundraisingActivitiesInd0false
IRS990/GamingActivitiesInd0false
IRS990/GoverningBodyVotingMembersCnt01
IRS990/GrantsToIndividualsInd0false
IRS990/GrantsToOrganizationsInd0false
IRS990/GrantToRelatedPersonInd0false
IRS990/GrossReceiptsAmt016363
IRS990/GroupReturnForAffiliatesInd0false
IRS990/IncludeFIN48FootnoteInd0false
IRS990/IndependentAuditFinclStmtInd0false
IRS990/IndependentVotingMemberCnt00
IRS990/IndoorTanningServicesInd0false
IRS990/InfoInScheduleOPartIIIInd0X
IRS990/InfoInScheduleOPartVIInd0X
IRS990/InvestmentInJointVentureInd0false
IRS990/IRPDocumentCnt00
IRS990/IRPDocumentW2GCnt00
IRS990/LandBldgEquipAccumDeprecAmt010638
IRS990/LandBldgEquipCostOrOtherBssAmt010638
IRS990/LegalDomicileStateCd0PA
IRS990/LoanOutstandingInd0true
IRS990/LoansFromOfficersDirectorsGrp/BOYAmt022908
IRS990/LoansFromOfficersDirectorsGrp/EOYAmt022570
IRS990/LobbyingActivitiesInd0false
IRS990/LocalChaptersInd0false
IRS990/MaterialDiversionOrMisuseInd0false
IRS990/MembersOrStockholdersInd0false
IRS990/MethodOfAccountingCashInd0X
IRS990/MinutesOfCommitteesInd0true
IRS990/MinutesOfGoverningBodyInd0true
IRS990/MissionDesc0TO PROMOTE GENE THERAPY RESEARCH RELEVANT TO NEUROLOGIC DISORDERS, INCLUDING BUT NOT LIMITED TO PARKINSON'S DISEASE.
IRS990/MoreThan5000KToIndividualsInd0false
IRS990/MoreThan5000KToOrgInd0false
IRS990/NetAssetsOrFundBalancesBOYAmt0-22908
IRS990/NetAssetsOrFundBalancesEOYAmt0-21056
IRS990/NoListedPersonsCompensatedInd0X
IRS990/NondeductibleContributionsInd0false
IRS990/OccupancyGrp/ManagementAndGeneralAmt011500
IRS990/OccupancyGrp/TotalAmt011500
IRS990/OfficeExpensesGrp/ManagementAndGeneralAmt0411
IRS990/OfficeExpensesGrp/TotalAmt0411
IRS990/OfficerMailingAddressInd0false
IRS990/OperateHospitalInd0false
IRS990/Organization501c3Ind0X
IRS990/OrgDoesNotFollowSFAS117Ind0X
IRS990/PartialLiquidationInd0false
IRS990/PoliticalCampaignActyInd0false
IRS990/PrincipalOfficerNm0ANDREW FREESE MD PHD
IRS990/ProfessionalFundraisingInd0false
IRS990/ProgSrvcAccomActyOtherGrp/Desc0TO SUPPORT RESEARCH FOR PARKINSON'S DISEASE GENE THERAPY, ANTICIPATE PUBLICATION OF PROCEEDINGS IN "EXPERIMENTAL NEUROLOGY- AND DISSEMINATE INFORMATION ON NOVEL GENE THERAPY APPROACHES.
IRS990/ProhibitedTaxShelterTransInd0false
IRS990/PYContributionsGrantsAmt012195
IRS990/PYExcessBenefitTransInd0false
IRS990/PYOtherExpensesAmt013949
IRS990/PYRevenuesLessExpensesAmt0-1754
IRS990/PYTotalExpensesAmt013949
IRS990/PYTotalRevenueAmt012195
IRS990/ReconcilationRevenueExpnssAmt01852
IRS990/RelatedEntityInd0false
IRS990/RelatedOrganizationCtrlEntInd0false
IRS990/ReportInvestmentsOtherSecInd0false
IRS990/ReportLandBuildingEquipmentInd0true
IRS990/ReportOtherAssetsInd0false
IRS990/ReportOtherLiabilitiesInd0false
IRS990/ReportProgramRelatedInvstInd0false
IRS990/RevenueAmt015429
IRS990/RtnEarnEndowmentIncmOthFndsGrp/BOYAmt0-22908
IRS990/RtnEarnEndowmentIncmOthFndsGrp/EOYAmt0-21056
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearAmt016363
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt012195
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt016226
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt018465
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt060000
IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt0123249
IRS990ScheduleA/InvestmentIncomeCYPct00.00000
IRS990ScheduleA/InvestmentIncomePYPct00.00000
IRS990ScheduleA/PubliclySupportedOrg509a2Ind0X
IRS990ScheduleA/PublicSupportCY509Pct01.00000
IRS990ScheduleA/PublicSupportPY509Pct01.00000
IRS990ScheduleA/PublicSupportTotal509Amt0123249
IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind0X
IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt016363
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt012195
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt016226
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt018465
IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt060000
IRS990ScheduleA/Total509Grp/TotalAmt0123249
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt016363
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt012195
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt016226
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt018465
IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt060000
IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt0123249
IRS990ScheduleB/ContributorInformationGrp/ContributorBusinessName/BusinessNameLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorNum0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine10RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/AddressLine20RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/City0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/State0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/ContributorUSAddress/ZIPCode0RESTRICTED
IRS990ScheduleB/ContributorInformationGrp/TotalContributionsAmt0RESTRICTED
IRS990/ScheduleBRequiredInd0true
IRS990ScheduleD/OtherLandBuildingsGrp/DepreciationAmt010638
IRS990ScheduleD/OtherLandBuildingsGrp/OtherCostOrOtherBasisAmt010638
IRS990/ScheduleJRequiredInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BalanceDueAmt022570
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/BoardOrCommitteeApprovalInd0true
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/DefaultInd0false
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanPurposeTxt0CASH REQUIREMENTS & BANK OVERDRAFTS
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/LoanToOrganizationInd0X
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/OriginalPrincipalAmt022570
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/PersonNm0DR FREESE
IRS990ScheduleL/LoansBtwnOrgInterestedPrsnGrp/WrittenAgreementInd0false
IRS990ScheduleL/TotalBalanceDueAmt022570
IRS990/ScheduleORequiredInd0false
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt0TO SUPPORT RESEARCH FOR PARKINSON'S DISEASE GENE THERAPY, ANTICIPATE PUBLICATION OF PROCEEDINGS IN "EXPERIMENTAL NEUROLOGY- AND DISSEMINATE INFORMATION ON NOVEL GENE THERAPY APPROACHES.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt1NO REVIEW WAS OR WILL BE CONDUCTED.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt2RECORDS AND FINANCIALS ARE KEPT ON SITE AND MADE AVAILABLE UPON REQUEST.
IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt3ROUNDING 0
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc0FORM 990, PAGE 2, PART III, LINE 4D
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc1FORM 990, PAGE 6, PART VI, LINE 11B
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc2FORM 990, PAGE 6, PART VI, LINE 19
IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc3FORM 990, PART XI, LINE 9
IRS990/SchoolOperatingInd0false
IRS990/SignificantChangeInd0false
IRS990/SignificantNewProgramSrvcInd0false
IRS990/StatesWhereCopyOfReturnIsFldCd0PA
IRS990/SubjectToProxyTaxInd0false
IRS990/TaxablePartyNotificationInd0false
IRS990/TaxExemptBondsInd0false
IRS990/TempOrPermanentEndowmentsInd0false
IRS990/TerminateOperationsInd0false
IRS990/TotalAssetsEOYAmt01514
IRS990/TotalAssetsGrp/BOYAmt00
IRS990/TotalAssetsGrp/EOYAmt01514
IRS990/TotalCompGreaterThan150KInd0false
IRS990/TotalContributionsAmt016363
IRS990/TotalEmployeeCnt00
IRS990/TotalFunctionalExpensesGrp/FundraisingAmt00
IRS990/TotalFunctionalExpensesGrp/ManagementAndGeneralAmt014511
IRS990/TotalFunctionalExpensesGrp/ProgramServicesAmt00
IRS990/TotalFunctionalExpensesGrp/TotalAmt014511
IRS990/TotalGrossUBIAmt00
IRS990/TotalLiabilitiesBOYAmt022908
IRS990/TotalLiabilitiesEOYAmt022570
IRS990/TotalLiabilitiesGrp/BOYAmt022908
IRS990/TotalLiabilitiesGrp/EOYAmt022570
IRS990/TotalNetAssetsFundBalanceGrp/BOYAmt0-22908
IRS990/TotalNetAssetsFundBalanceGrp/EOYAmt0-21056
IRS990/TotalRevenueGrp/TotalRevenueColumnAmt016363
IRS990/TotLiabNetAssetsFundBalanceGrp/BOYAmt00
IRS990/TotLiabNetAssetsFundBalanceGrp/EOYAmt01514
IRS990/TrnsfrExmptNonChrtblRltdOrgInd0false
IRS990/TypeOfOrganizationCorpInd0X
IRS990/UnrelatedBusIncmOverLimitInd0false
IRS990/UponRequestInd0X
IRS990/USAddress/AddressLine1Txt01803 PINE ST
IRS990/USAddress/AddressLine2Txt0STE 1-F
IRS990/USAddress/CityNm0PHILADELPHIA
IRS990/USAddress/StateAbbreviationCd0PA
IRS990/USAddress/ZIPCd019103
IRS990/VotingMembersGoverningBodyCnt01
IRS990/VotingMembersIndependentCnt00
IRS990/WebsiteAddressTxt0N/A
IRS990/WhistleblowerPolicyInd0false
ReturnHeader/BuildTS02016-12-15 16:53:06Z
ReturnHeader/BusinessOfficerGrp/DiscussWithPaidPreparerInd0true
ReturnHeader/BusinessOfficerGrp/PersonNm0ANDREW FREESE MD PHD
ReturnHeader/BusinessOfficerGrp/PersonTitleTxt0PRESIDENT
ReturnHeader/BusinessOfficerGrp/PhoneNum02675148950
ReturnHeader/BusinessOfficerGrp/SignatureDt02016-05-12
ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt0CNS GENE THERAPY CONSORTIUM
ReturnHeader/Filer/BusinessNameControlTxt0CNSG
ReturnHeader/Filer/EIN0233032900
ReturnHeader/Filer/PhoneNum02675148950
ReturnHeader/Filer/USAddress/AddressLine1Txt01500 JFK BLVD SUITE 1450
ReturnHeader/Filer/USAddress/CityNm0PHILADELPHIA
ReturnHeader/Filer/USAddress/StateAbbreviationCd0PA
ReturnHeader/Filer/USAddress/ZIPCd019102
ReturnHeader/PreparerFirmGrp/PreparerFirmEIN0453816544
ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt0JW KELLY ASSOCIATES LLC
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt01 BELMONT AVE STE 412
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm0BALA CYNWYD
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd0PA
ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd0190041607
ReturnHeader/PreparerPersonGrp/PhoneNum06106647000
ReturnHeader/PreparerPersonGrp/PreparationDt02016-08-29
ReturnHeader/PreparerPersonGrp/PreparerPersonNm0REGINA W KELLY CPA
ReturnHeader/ReturnTs02016-09-08T15:01:52-05:00
ReturnHeader/ReturnTypeCd0990
ReturnHeader/TaxPeriodBeginDt02015-01-01
ReturnHeader/TaxPeriodEndDt02015-12-31
ReturnHeader/TaxYr02015

Document Assets

No mirrored PDF or thumbnail assets are attached yet.